Compound class:
Synthetic organic
Comment: Tetroxoprim belongs to the diaminopyrimidine class of antibacterial compounds. Functionally, the compound is a selective inhibitor of bacterial dihydrofolate reductase (DHFR) [1].
|
|
No information available. |
Summary of Clinical Use |
There is no information regarding approval for clinical use of this drug on the US FDA or European Medicines Agency websites. The compound in combination with sulfadiazine (co-tetroxazine) has been clinically evaluated for the treatment of susceptible bacterial infections [3]. |